low healthVERIFIED◈ 3 SOURCES
US is requiring weight-loss drug makers to warn about possible loss of eye sight
Verified: 3 outlets in 2 countries have reported this story since Nov 9.
📍 United States, US·🕐 6h ago·3 outlets
Close to 30 million Americans are taking the drugs
How sure are we
✓ Verified · 3 outlets
Two or more outlets reported this story and its reliability score reached 65%, so WorldPulse marks it verified. That means more than one outlet says so, not that it is proven true.
Who reported it
Location
Verification Log1
cross checkconfirmed90%
[Claude] Report 2 covers the same FDA requirement for GLP-1 weight-loss drug makers to warn of possible vision loss, adding only the figure of roughly 30 million users, which does not conflict with Report 1.
6h agoPowered by WorldPulse Verification Engine
Reliability
Reliability ScoreVery high
93%Independent outlets3
Statusverified
AI checknone yet
Community flags0
Score bands
Very high80–100%
A highly rated outlet, or several independent outletsHigh60–79%
One well-rated outlet so farModerate40–59%
A lower-rated or state-run outlet, or one report of something seriousLow20–39%
A low-rated outlet on a serious or sensitive storyVery low0–19%
Treat it as unconfirmedWhat moves the score
◎
Outlet ratingThe outlet’s rating in WorldPulse’s list of sources starts the score
⇄
Independent outletsEach further outlet that reports the story closes 40% of the gap to 98%
±
Report detailsA few points either way: a summary and a place add a little; state-run outlets on conflict, politics or security, and single reports marked high or critical, lose some
Not in the score: AI checks and reader flags. Verified is separate: two or more independent outlets and a score of at least 65%.
Very high · How we score this
Risk Score
low risk